Extracorporeal Clearance of Levetiracetam During Continuous Venovenous Hemofiltration in a Critically Ill Patient and New Dosing Recommendation

J Clin Pharmacol. 2017 Apr;57(4):536-537. doi: 10.1002/jcph.844. Epub 2016 Nov 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / metabolism*
  • Critical Illness / therapy*
  • Dose-Response Relationship, Drug
  • Extracorporeal Circulation / methods
  • Hemofiltration / methods*
  • Hemofiltration / trends
  • Humans
  • Levetiracetam
  • Male
  • Metabolic Clearance Rate / drug effects
  • Metabolic Clearance Rate / physiology*
  • Piracetam / administration & dosage
  • Piracetam / analogs & derivatives*
  • Piracetam / metabolism

Substances

  • Anticonvulsants
  • Levetiracetam
  • Piracetam